Google has added an investment of 1 billion dollars to its competitor Anthropic, OpenAI.

Previously, Google had pledged to invest an additional 2 billion USD in Anthropic. Reports indicate that Anthropic will also receive an additional 2 billion USD in Silicon Valley venture capital, and this Trade is expected to increase its valuation to 60 billion USD, three times the previous valuation.

wallstreetcn02:07 ET

Google Parent-Owned Startup To Launch AI-Designed Drug Trials By Year-End, Partnering With Eli Lilly And Novartis To Tackle Major Diseases

Benzinga01:44 ET

Express News | Google Invests Further $1Bn in OpenAI Rival Anthropic - FT

Reuters00:01 ET

Tech Companies Could Report Strong 4Q Earnings on AI Tailwind -- Market Talk

WSJ22:20 ET

Why Trump May Need Big Companies to Spend Less on Stock Buybacks

MarketWatch22:19 ET

The speed of drug research and development has increased by ten times! Google states that the first AI-designed medication will enter testing by the end of the year.

Demis Hassabis, the founder of Google's drug development company, stated that traditional drug development usually takes 5 to 10 years, while with the help of AI technology, this process may be accelerated by 10 times. Former USA Treasury Secretary Summers once commented that AI's relationship with the Internet Plus-Related is similar to that of computers with calculators.

wallstreetcn21:36 ET